369 related articles for article (PubMed ID: 10952950)
1. Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis.
Belton O; Byrne D; Kearney D; Leahy A; Fitzgerald DJ
Circulation; 2000 Aug; 102(8):840-5. PubMed ID: 10952950
[TBL] [Abstract][Full Text] [Related]
2. Optimal suppression of thromboxane A(2) formation by aspirin during percutaneous transluminal coronary angioplasty: no additional effect of a selective cyclooxygenase-2 inhibitor.
Kearney D; Byrne A; Crean P; Cox D; Fitzgerald DJ
J Am Coll Cardiol; 2004 Feb; 43(4):526-31. PubMed ID: 14975458
[TBL] [Abstract][Full Text] [Related]
3. Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice.
Praticò D; Tillmann C; Zhang ZB; Li H; FitzGerald GA
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3358-63. PubMed ID: 11248083
[TBL] [Abstract][Full Text] [Related]
4. Oxidant stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina.
Cipollone F; Ciabattoni G; Patrignani P; Pasquale M; Di Gregorio D; Bucciarelli T; Davì G; Cuccurullo F; Patrono C
Circulation; 2000 Aug; 102(9):1007-13. PubMed ID: 10961965
[TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
Capone ML; Tacconelli S; Sciulli MG; Grana M; Ricciotti E; Minuz P; Di Gregorio P; Merciaro G; Patrono C; Patrignani P
Circulation; 2004 Mar; 109(12):1468-71. PubMed ID: 15037526
[TBL] [Abstract][Full Text] [Related]
6. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2.
McAdam BF; Catella-Lawson F; Mardini IA; Kapoor S; Lawson JA; FitzGerald GA
Proc Natl Acad Sci U S A; 1999 Jan; 96(1):272-7. PubMed ID: 9874808
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cyclooxygenase-2 aggravates doxorubicin-mediated cardiac injury in vivo.
Dowd NP; Scully M; Adderley SR; Cunningham AJ; Fitzgerald DJ
J Clin Invest; 2001 Aug; 108(4):585-90. PubMed ID: 11518732
[TBL] [Abstract][Full Text] [Related]
8. Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2.
Caughey GE; Cleland LG; Penglis PS; Gamble JR; James MJ
J Immunol; 2001 Sep; 167(5):2831-8. PubMed ID: 11509629
[TBL] [Abstract][Full Text] [Related]
9. Human pharmacology of naproxen sodium.
Capone ML; Tacconelli S; Sciulli MG; Anzellotti P; Di Francesco L; Merciaro G; Di Gregorio P; Patrignani P
J Pharmacol Exp Ther; 2007 Aug; 322(2):453-60. PubMed ID: 17473175
[TBL] [Abstract][Full Text] [Related]
10. Effects of vitamin E supplementation on F(2)-isoprostane and thromboxane biosynthesis in healthy cigarette smokers.
Patrignani P; Panara MR; Tacconelli S; Seta F; Bucciarelli T; Ciabattoni G; Alessandrini P; Mezzetti A; Santini G; Sciulli MG; Cipollone F; Davì G; Gallina P; Bon GB; Patrono C
Circulation; 2000 Aug; 102(5):539-45. PubMed ID: 10920066
[TBL] [Abstract][Full Text] [Related]
11. Prostacyclin, thromboxane A and the effect of low-dose ASA in pregnancies at high risk for hypertensive disorders.
Vainio M; Riutta A; Koivisto AM; Mäenpää J
Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1119-23. PubMed ID: 15548142
[TBL] [Abstract][Full Text] [Related]
12. Generation of 8-epi-prostaglandin F(2alpha) in isolated rat kidney glomeruli by a radical-independent mechanism.
Klein T; Neuhaus K; Reutter F; Nüsing RM
Br J Pharmacol; 2001 Jul; 133(5):643-50. PubMed ID: 11429387
[TBL] [Abstract][Full Text] [Related]
13. In vivo lipid peroxidation and platelet activation in cystic fibrosis.
Ciabattoni G; Davì G; Collura M; Iapichino L; Pardo F; Ganci A; Romagnoli R; Maclouf J; Patrono C
Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1195-201. PubMed ID: 11029317
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of the thromboxane A2/prostacyclin ratio in the urine of patients with retinal vascular occlusion through the low-dose-aspirin therapy using the gas chromatography/selected ion monitoring method.
Mizugaki M; Hishinuma T; Matsumura E; Murai Y; Yamazaki T; Yamanobe S; Tamai M
Prostaglandins Other Lipid Mediat; 1999 Nov; 58(5-6):253-62. PubMed ID: 10593167
[TBL] [Abstract][Full Text] [Related]
15. Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage.
Saloheimo P; Juvela S; Riutta A; Pyhtinen J; Hillbom M
Thromb Res; 2005; 115(5):367-73. PubMed ID: 15733969
[TBL] [Abstract][Full Text] [Related]
16. Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation.
McAdam BF; Mardini IA; Habib A; Burke A; Lawson JA; Kapoor S; FitzGerald GA
J Clin Invest; 2000 May; 105(10):1473-82. PubMed ID: 10811855
[TBL] [Abstract][Full Text] [Related]
17. Kidney Transplantation in a Patient Lacking Cytosolic Phospholipase A
Mitchell JA; Knowles RB; Kirkby NS; Reed DM; Edin ML; White WE; Chan MV; Longhurst H; Yaqoob MM; Milne GL; Zeldin DC; Warner TD
Circ Res; 2018 Feb; 122(4):555-559. PubMed ID: 29298774
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase inhibition and thrombogenicity.
Catella-Lawson F; Crofford LJ
Am J Med; 2001 Feb; 110 Suppl 3A():28S-32S. PubMed ID: 11173047
[TBL] [Abstract][Full Text] [Related]
19. Role of COX-2-derived metabolites in regulation of the renal hemodynamic response to norepinephrine.
Llinás MT; López R; Rodríguez F; Roig F; Salazar FJ
Am J Physiol Renal Physiol; 2001 Nov; 281(5):F975-82. PubMed ID: 11592955
[TBL] [Abstract][Full Text] [Related]
20. Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome: therapeutic use of the cyclooxygenase-2 inhibitor nimesulide.
Nüsing RM; Reinalter SC; Peters M; Kömhoff M; Seyberth HW
Clin Pharmacol Ther; 2001 Oct; 70(4):384-90. PubMed ID: 11673754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]